• Western blot analysis of lysates from SW480 cells, primary antibody was diluted at 1:1000, 4°C over night

Anti-RNF183 antibody (4-54 aa) (STJ193824)

SKU:
STJ193824

Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-E3 ubiquitin-protein ligase RNF183 (4-54 aa) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: RNF183
Gene ID: 138065
Uniprot ID: RN183_HUMAN
Immunogen Region: 4-54 aa
Specificity: This antibody detects endogenous levels of RN183 at Human/Mouse
Immunogen: Synthesized peptide derived from the human RN183 at the amino acid range 4-54
Post Translational Modifications Autoubiquitinated (in vitro).
Function Acts as a E3 ubiquitin ligase catalyzing the covalent attachment of ubiquitin moieties onto substrate proteins. Triggers apoptosis in response to prolonged ER stress by mediating the polyubiquitination and subsequent proteasomal degradation of BCL2L1. May collaborate with FATE1 to restrain BIK protein levels thus regulating apoptotic signaling.
Protein Name E3 Ubiquitin-Protein Ligase Rnf183
Cellular Localisation Endoplasmic Reticulum Membrane
Single-Pass Type Iv Membrane Protein
Endoplasmic Reticulum
Golgi Apparatus
Cis-Golgi Network Membrane
Lysosome Membrane
Alternative Antibody Names Anti-E3 Ubiquitin-Protein Ligase Rnf183 antibody
Anti-RNF183 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance